NewslettersHepatic Cell NewsUncategorizedFasting Improves Therapeutic Response in Hepatocellular Carcinoma through p53-Dependent Metabolic SynergismBy Justin.choi - January 26, 2022013Scientists showed in hepatocellular carcinoma (HCC) cells, xenografts, and patient-derived organoids that fasting improved sorafenib efficacy and acted synergistically to sensitize sorafenib-resistant HCC.[Science Advances] 7992332 BBBBBBBB items 1 apa 0 default asc 1 171135 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/Full Article